{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "MAP2K2",
                "DNA Alteration": "c.383C>T",
                "GeneMutation": "p.P128L Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "10.37%"
            },
            {
                "Gene": "NT5C2",
                "DNA Alteration": "c.1100G>A",
                "GeneMutation": "p.R367Q Frameshift-GOF",
                "VariantAlleleFraction": "11.12%"
            },
            {
                "Gene": "PHF6",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R225X Nonsense-GOF",
                "VariantAlleleFraction": "6.78%"
            },
            {
                "Gene": "HSP90B1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.I66T Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.16%"
            },
            {
                "Gene": "FBXW7",
                "DNA Alteration": "c.1394G>A",
                "GeneMutation": "p.R465H Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "3.01%"
            },
            {
                "Gene": "CD74",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.P98S Stopgain-LOF",
                "VariantAlleleFraction": "3.42%"
            },
            {
                "Gene": "FGFR3",
                "DNA Alteration": "c.1118A>G",
                "GeneMutation": "p.R248C Spliceregionvariant-LOF",
                "VariantAlleleFraction": "8.43%"
            },
            {
                "Gene": "BRCA2",
                "DNA Alteration": "c.5946delT",
                "GeneMutation": "p.S1982Rfs*22 Frameshift-GOF",
                "VariantAlleleFraction": "7.83%"
            },
            {
                "Gene": "DNMT3A",
                "DNA Alteration": "c.2711C>T",
                "GeneMutation": "p.P904L Stopgain-LOF",
                "VariantAlleleFraction": "1.5%"
            },
            {
                "Gene": "PTPN11",
                "DNA Alteration": "c.1508G>C",
                "GeneMutation": "p.G503A Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "5.07%"
            },
            {
                "Gene": "MTOR",
                "DNA Alteration": "c.5662T>C",
                "GeneMutation": "p.F1888L Frameshift-LOF",
                "VariantAlleleFraction": "7.91%"
            },
            {
                "Gene": "MTOR",
                "DNA Alteration": "c.5662T>C",
                "GeneMutation": "p.F1888L Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "4.59%"
            }
        ],
        "Germline": []
    }
}